Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind, Parallel Group, Repeat Dose Pharmacokinetic and Pharmacodynamic Study of Four Doses of ATL-962 (40mg, 80mg, 120mg 240mg) in Otherwise-Healthy Obese Volunteers

NCT00148382 is registered in ClinicalTrials.gov with Alizyme as lead sponsor.

NCT NCT00148382
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148382 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind, Parallel Group, Repeat Dose Pharmacokinetic and Pharmacodynamic Study of Four Doses of ATL-962 (40mg, 80mg, 120mg 240mg) in Otherwise-Healthy Obese Volunteers
Lead sponsor
Alizyme
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2005
Completion date
July 31, 2005
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity